Digital PCR Leverages Microfluidic Array Tech

Thermo Fisher Scientific PCR System
Applied Biosystems QuantStudio Absolute Q Digital PCR System, the first integrated digital PCR solution, is ideal for oncology, cell and gene therapy development and other research applications. [Source: Thermo Fisher Scientific]

Thermo Fisher Scientific debuts the Applied Biosystems QuantStudio Absolute Q Digital PCR System, the first fully integrated digital PCR (dPCR) system designed to provide highly accurate and consistent results within 90 minutes. Unlike, multi-instrument workflows required for traditional dPCR, the QuantStudio Absolute Q System uses microfluidic array technology and simplified workflows, designed to improve data accuracy and consistency. Hands-on time is just five minutes, minimizing the risk of user error. The dPCR technology that powers the QuantStudio Absolute Q solution is already in use by biotech companies and academic institutions for longitudinal monitoring of cancer-driving mutations in liquid biopsy, precise quantification of gene inserts for cell therapy development, and copy number variation studies for earlier identification of genetic conditions in newborns.

 

Thermo Fisher Scientific

www.thermofisher.com

This site uses Akismet to reduce spam. Learn how your comment data is processed.